SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $31.85 million. The enterprise value is -$13.49 million.
| Market Cap | 31.85M |
| Enterprise Value | -13.49M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 9.95 million shares outstanding. The number of shares has increased by 47.42% in one year.
| Current Share Class | 9.95M |
| Shares Outstanding | 9.95M |
| Shares Change (YoY) | +47.42% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 1.99% |
| Owned by Institutions (%) | 34.07% |
| Float | 7.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.67 |
| Forward PS | 13.51 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.57 |
| Quick Ratio | 7.09 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.16% and return on invested capital (ROIC) is -168.12%.
| Return on Equity (ROE) | -21.16% |
| Return on Assets (ROA) | -25.16% |
| Return on Invested Capital (ROIC) | -168.12% |
| Return on Capital Employed (ROCE) | -39.08% |
| Weighted Average Cost of Capital (WACC) | 10.38% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | -$561,222 |
| Employee Count | 18 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.92% in the last 52 weeks. The beta is 1.22, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -32.92% |
| 50-Day Moving Average | 4.20 |
| 200-Day Moving Average | 5.43 |
| Relative Strength Index (RSI) | 30.63 |
| Average Volume (20 Days) | 61,546 |
Short Selling Information
The latest short interest is 450,240, so 4.52% of the outstanding shares have been sold short.
| Short Interest | 450,240 |
| Short Previous Month | 420,517 |
| Short % of Shares Out | 4.52% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 0.85 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $18.88 million and -$10.10 million in losses. Loss per share was -$1.11.
| Revenue | 18.88M |
| Gross Profit | 18.88M |
| Operating Income | -23.95M |
| Pretax Income | -10.10M |
| Net Income | -10.10M |
| EBITDA | n/a |
| EBIT | -23.95M |
| Loss Per Share | -$1.11 |
Balance Sheet
The company has $47.17 million in cash and $1.82 million in debt, with a net cash position of $45.34 million or $4.56 per share.
| Cash & Cash Equivalents | 47.17M |
| Total Debt | 1.82M |
| Net Cash | 45.34M |
| Net Cash Per Share | $4.56 |
| Equity (Book Value) | 59.05M |
| Book Value Per Share | 5.93 |
| Working Capital | 43.71M |
Cash Flow
| Operating Cash Flow | -12.05M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -12.05M |
| FCF Per Share | -$1.21 |
Margins
Gross margin is 100.00%, with operating and profit margins of -126.86% and -53.50%.
| Gross Margin | 100.00% |
| Operating Margin | -126.86% |
| Pretax Margin | -53.50% |
| Profit Margin | -53.50% |
| EBITDA Margin | n/a |
| EBIT Margin | -126.86% |
| FCF Margin | n/a |
Dividends & Yields
SCYNEXIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -47.42% |
| Shareholder Yield | -47.42% |
| Earnings Yield | -34.65% |
| FCF Yield | -38.19% |
Analyst Forecast
The average price target for SCYNEXIS is $32.67, which is 920.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.67 |
| Price Target Difference | 920.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -11.91% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |